Skip to content
2000
image of In Silico Multi-omics Analyses of Kinesin Family Member 15 in Pan-Cancer and Validation in Tissue Microarray
file format pdf download PDF

Abstract

Introduction

Kinesin family member 15 (KIF15) is a molecular motor protein that participates in bipolar spindle assembly and centrosome separation during metaphase in normal cells. However, accumulating evidence has shown that KIF15 is aberrantly regulated in the state of malignancy and is associated with the progression of cancers.

Materials and Methods

We analyzed the mRNA expression, protein expression, single-cell gene expression, prognoses, and immune reactivities of KIF15 using the data from various sources, including the Cancer Cell Line Encyclopedia, The Cancer Genome Atlas database, the Clinical Proteomic Tumor Analysis Consortium Confirmatory/Discovery database, and Cancer Single-cell Expression Map. Additionally, immunohistochemistry was performed to validate KIF15 protein expression in human tumor samples.

Results

The data from the present pan-cancer analysis elucidated that KIF15 expression was increased in more than 25 human tumors. Furthermore, it was found to be highly correlated with biological pathways, immune cell infiltration, and poor prognoses across multiple cancers. Additionally, tissue microarray analysis confirmed abundant cytoplasmic KIF15 expression in ovarian serous carcinoma and colorectal adenocarcinoma, with significantly higher levels compared to adjacent normal tissues.

Discussion

Consistent patterns of high KIF15 expression were also evident across various cancer cell lines in the CCLE dataset. Collectively, these observations suggest KIF15 is intimately involved in the progression of multiple human cancers. By analyzing both the proteins that interact with KIF15 and the genes that show correlation with its expression, KEGG pathway enrichment indicated that processes such as cell cycle regulation, gap and tight junction dynamics, involvement of microRNAs in cancer, and the p53 signaling pathway may underlie the role of KIF15 in cancer development.

Conclusion

KIF15 may serve as a potential biomarker and oncogenic factor in multiple cancer types.

© 2026 The Author(s). Published by Bentham Science Publishers.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/ccdt/10.2174/0115680096420482251130063549
2026-04-03
2026-04-17

  • From This Site

    /content/journals/ccdt/10.2174/0115680096420482251130063549
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/ccdt/10.2174/0115680096420482251130063549/BMS-CCDT-2025-HT48-6961-8.html?itemId=/content/journals/ccdt/10.2174/0115680096420482251130063549&mimeType=html&fmt=ahah

References

  1. Boleti H. Karsenti E. Vernos I. Xklp2, a novel Xenopus centrosomal kinesin-like protein required for centrosome separation during mitosis. Cell 1996 84 1 49 59 10.1016/S0092‑8674(00)80992‑7 8548825
    [Google Scholar]
  2. Sueishi M. Takagi M. Yoneda Y. The forkhead-associated domain of Ki-67 antigen interacts with the novel kinesin-like protein Hklp2. J. Biol. Chem. 2000 275 37 28888 28892 10.1074/jbc.M003879200 10878014
    [Google Scholar]
  3. Fagerberg L. Hallström B.M. Oksvold P. Kampf C. Djureinovic D. Odeberg J. Habuka M. Tahmasebpoor S. Danielsson A. Edlund K. Asplund A. Sjöstedt E. Lundberg E. Szigyarto C.A.K. Skogs M. Takanen J.O. Berling H. Tegel H. Mulder J. Nilsson P. Schwenk J.M. Lindskog C. Danielsson F. Mardinoglu A. Sivertsson Å. von Feilitzen K. Forsberg M. Zwahlen M. Olsson I. Navani S. Huss M. Nielsen J. Ponten F. Uhlén M. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell. Proteomics 2014 13 2 397 406 10.1074/mcp.M113.035600 24309898
    [Google Scholar]
  4. Tanenbaum M.E. Macůrek L. Janssen A. Geers E.F. Alvarez-Fernández M. Medema R.H. Kif15 cooperates with eg5 to promote bipolar spindle assembly. Curr. Biol. 2009 19 20 1703 1711 10.1016/j.cub.2009.08.027 19818618
    [Google Scholar]
  5. Sturgill E.G. Ohi R. Kinesin-12 differentially affects spindle assembly depending on its microtubule substrate. Curr. Biol. 2013 23 14 1280 1290 10.1016/j.cub.2013.05.043 23791727
    [Google Scholar]
  6. Zou Y.J. Shan M.M. Wan X. Liu J.C. Zhang K.H. Ju J.Q. Xing C.H. Sun S.C. Kinesin KIF15 regulates tubulin acetylation and spindle assembly checkpoint in mouse oocyte meiosis. Cell. Mol. Life Sci. 2022 79 8 422 10.1007/s00018‑022‑04447‑3 35835966
    [Google Scholar]
  7. Wu S. Lv L. Li L. Wang L. Mao B. Li J. Shen X. Ge R. Wong C.K.C. Sun F. Cheng C.Y. KIF15 supports spermatogenesis via its effects on Sertoli cell microtubule, actin, vimentin, and septin cytoskeletons. Endocrinology 2021 162 4 bqab010 10.1210/endocr/bqab010 33453102
    [Google Scholar]
  8. Liu M. Nadar V.C. Kozielski F. Kozlowska M. Yu W. Baas P.W. Kinesin-12, a mitotic microtubule-associated motor protein, impacts axonal growth, navigation, and branching. J. Neurosci. 2010 30 44 14896 14906 10.1523/JNEUROSCI.3739‑10.2010 21048148
    [Google Scholar]
  9. Dong Z. Zhuo R. Wang Q. Sun Y. Zhou Z. Wu R. Liu Y. Liu M. Kif15 regulates Coro1a+ cell migration and phagocytosis in zebrafish after spinal cord injury. Int. Immunopharmacol. 2025 146 113874 10.1016/j.intimp.2024.113874 39709909
    [Google Scholar]
  10. Wang J. Tu Q. Zhang S. He X. Ma C. Qian X. Wu R. Shi X. Yang Z. Liu Y. Dong Z. Liu M. Kif15 deficiency contributes to depression-like behavior in mice. Metab. Brain Dis. 2023 38 7 2369 2381 10.1007/s11011‑023‑01238‑y 37256467
    [Google Scholar]
  11. Bakhoum S.F. Silkworth W.T. Nardi I.K. Nicholson J.M. Compton D.A. Cimini D. The mitotic origin of chromosomal instability. Curr. Biol. 2014 24 4 R148 R149 10.1016/j.cub.2014.01.019 24556433
    [Google Scholar]
  12. Al-Rawi D.H. Lettera E. Li J. DiBona M. Bakhoum S.F. Targeting chromosomal instability in patients with cancer. Nat. Rev. Clin. Oncol. 2024 21 9 645 659 10.1038/s41571‑024‑00923‑w 38992122
    [Google Scholar]
  13. Chen X. Agustinus A.S. Li J. DiBona M. Bakhoum S.F. Chromosomal instability as a driver of cancer progression. Nat. Rev. Genet. 2025 26 1 31 46 10.1038/s41576‑024‑00761‑7 39075192
    [Google Scholar]
  14. Malaby H.L.H. Dumas M.E. Ohi R. Stumpff J. Kinesin-binding protein ensures accurate chromosome segregation by buffering KIF18A and KIF15. J. Cell Biol. 2019 218 4 1218 1234 10.1083/jcb.201806195 30709852
    [Google Scholar]
  15. Li Q. Qiu J. Yang H. Sun G. Hu Y. Zhu D. Deng Z. Wang X. Tang J. Jiang R. Kinesin family member 15 promotes cancer stem cell phenotype and malignancy via reactive oxygen species imbalance in hepatocellular carcinoma. Cancer Lett. 2020 482 112 125 10.1016/j.canlet.2019.11.008 31733289
    [Google Scholar]
  16. Wang J. Guo X. Xie C. Jiang J. KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway. Br. J. Cancer 2017 117 2 245 255 10.1038/bjc.2017.165 28595260
    [Google Scholar]
  17. Yu W. Han S. Hu S. Ru L. Hua C. Xue G. Zhang G. Lv K. Ge H. Wang M. Zheng L. Zhou J. Hou S. Teng Y. Deng W. Guo W. KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300. Int. J. Biol. Sci. 2024 20 13 5127 5144 10.7150/ijbs.98668 39430242
    [Google Scholar]
  18. Milic B. Chakraborty A. Han K. Bassik M.C. Block S.M. KIF15 nanomechanics and kinesin inhibitors, with implications for cancer chemotherapeutics. Proc. Natl. Acad. Sci. USA 2018 115 20 E4613 E4622 10.1073/pnas.1801242115 29703754
    [Google Scholar]
  19. Han C. Yang B. Deng Y. Hu P. Hu B. Liu X. Wang T. Li C. Liu J. Yuan H. Atractylenolide I ameliorated the growth and enzalutamide resistance of castration-resistant prostate cancer by targeting KIF15. Chin. Med. 2025 20 1 35 10.1186/s13020‑025‑01086‑1 40087774
    [Google Scholar]
  20. Li S. Wang S. Zhang L. Wu X. Tian L. Zou J. Pi G. METTL3 methylated KIF15 promotes nasopharyngeal carcinoma progression and radiation resistance by blocking ATG7-mediated autophagy through the activation of STAT3 pathway. Transl. Oncol. 2025 51 102161 10.1016/j.tranon.2024.102161 39504712
    [Google Scholar]
  21. Yang J. Liu L. Xu X. Zeng H. KIF15 promotes the development and progression of chordoma via activating PI3K-AKT signalling pathway. Heliyon 2024 10 8 e29386 10.1016/j.heliyon.2024.e29386 38681556
    [Google Scholar]
  22. Bi H. Hou X. Shen Q. Liu Z. Zhu X. Ma L. Lu J. Knockdown of KIF15 suppresses proliferation of prostate cancer cells and induces apoptosis through PI3K/Akt signaling pathway. Cell Death Discov. 2023 9 1 326 10.1038/s41420‑023‑01625‑5 37658042
    [Google Scholar]
  23. Chen C. Wang Y. Li Y. Zhang C. VIRMA facilitates triple-negative breast cancer progression via increasing m6a-dependent KIF15 expression. Discov. Med. 2023 35 178 787 795 10.24976/Discov.Med.202335178.73 37811616
    [Google Scholar]
  24. Cai Y. Lai Q. Zhang X. Zhang Y. Zhang M. Gu S. Qin Y. Hou J. Zhao L. Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma. Korean J. Physiol. Pharmacol. 2023 27 5 457 470 10.4196/kjpp.2023.27.5.457 37641808
    [Google Scholar]
  25. Shi D. Wang J. Deng Q. Kong X. Dong Y. Yang Y. Xu Y. Ling L. Jiao Y. Yu S. KIF15 knockdown inhibits colorectal cancer proliferation and migration through affecting the ubiquitination modification of NRAS. Am. J. Cancer Res. 2023 13 10 4944 4960 [PMID: 37970344
    [Google Scholar]
  26. Huang J. Sun X. Diao G. Li R. Guo J. Han J. RETRACTED: KIF15 Knockdown inhibits the development of endometrial cancer by suppressing epithelial‐mesenchymal transition and stemness through Wnt/β‐catenin signaling. Environ. Toxicol. 2023 38 8 1824 1834 10.1002/tox.23809 37186152
    [Google Scholar]
  27. Badraldin S.Q. Alfarttoosi K.H. Sameer H.N. Bishoyi A.K. Ganesan S. Shankhyan A. Ray S. Yaseen A. Athab Z.H. Adil M. The multifaceted role of KIF15 in cancer progression and therapy. Invest. New Drugs 2025 43 4 1022 1042 10.1007/s10637‑025‑01572‑1 40817978
    [Google Scholar]
  28. Vivian J. Rao A.A. Nothaft F.A. Ketchum C. Armstrong J. Novak A. Pfeil J. Narkizian J. Deran A.D. Musselman-Brown A. Schmidt H. Amstutz P. Craft B. Goldman M. Rosenbloom K. Cline M. O’Connor B. Hanna M. Birger C. Kent W.J. Patterson D.A. Joseph A.D. Zhu J. Zaranek S. Getz G. Haussler D. Paten B. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 2017 35 4 314 316 10.1038/nbt.3772 28398314
    [Google Scholar]
  29. Ghandi M. Huang F.W. Jané-Valbuena J. Kryukov G.V. Lo C.C. McDonald E.R. Barretina J. Gelfand E.T. Bielski C.M. Li H. Hu K. Andreev-Drakhlin A.Y. Kim J. Hess J.M. Haas B.J. Aguet F. Weir B.A. Rothberg M.V. Paolella B.R. Lawrence M.S. Akbani R. Lu Y. Tiv H.L. Gokhale P.C. de Weck A. Mansour A.A. Oh C. Shih J. Hadi K. Rosen Y. Bistline J. Venkatesan K. Reddy A. Sonkin D. Liu M. Lehar J. Korn J.M. Porter D.A. Jones M.D. Golji J. Caponigro G. Taylor J.E. Dunning C.M. Creech A.L. Warren A.C. McFarland J.M. Zamanighomi M. Kauffmann A. Stransky N. Imielinski M. Maruvka Y.E. Cherniack A.D. Tsherniak A. Vazquez F. Jaffe J.D. Lane A.A. Weinstock D.M. Johannessen C.M. Morrissey M.P. Stegmeier F. Schlegel R. Hahn W.C. Getz G. Mills G.B. Boehm J.S. Golub T.R. Garraway L.A. Sellers W.R. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 2019 569 7757 503 508 10.1038/s41586‑019‑1186‑3 31068700
    [Google Scholar]
  30. Chen F. Chandrashekar D.S. Varambally S. Creighton C.J. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat. Commun. 2019 10 1 5679 10.1038/s41467‑019‑13528‑0 31831737
    [Google Scholar]
  31. Tang Z. Kang B. Li C. Chen T. Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019 47 W1 W556 W560 10.1093/nar/gkz430 31114875
    [Google Scholar]
  32. Liu J. Lichtenberg T. Hoadley K.A. Poisson L.M. Lazar A.J. Cherniack A.D. Kovatich A.J. Benz C.C. Levine D.A. Lee A.V. Omberg L. Wolf D.M. Shriver C.D. Thorsson V. Caesar-Johnson S.J. Demchok J.A. Felau I. Kasapi M. Ferguson M.L. Hutter C.M. Sofia H.J. Tarnuzzer R. Wang Z. Yang L. Zenklusen J.C. Zhang J.J. Chudamani S. Liu J. Lolla L. Naresh R. Pihl T. Sun Q. Wan Y. Wu Y. Cho J. DeFreitas T. Frazer S. Gehlenborg N. Getz G. Heiman D.I. Kim J. Lawrence M.S. Lin P. Meier S. Noble M.S. Saksena G. Voet D. Zhang H. Bernard B. Chambwe N. Dhankani V. Knijnenburg T. Kramer R. Leinonen K. Liu Y. Miller M. Reynolds S. Shmulevich I. Thorsson V. Zhang W. Akbani R. Broom B.M. Hegde A.M. Ju Z. Kanchi R.S. Korkut A. Li J. Liang H. Ling S. Liu W. Lu Y. Mills G.B. Ng K-S. Rao A. Ryan M. Wang J. Weinstein J.N. Zhang J. Abeshouse A. Armenia J. Chakravarty D. Chatila W.K. de Bruijn I. Gao J. Gross B.E. Heins Z.J. Kundra R. La K. Ladanyi M. Luna A. Nissan M.G. Ochoa A. Phillips S.M. Reznik E. Sanchez-Vega F. Sander C. Schultz N. Sheridan R. Sumer S.O. Sun Y. Taylor B.S. Wang J. Zhang H. Anur P. Peto M. Spellman P. Benz C. Stuart J.M. Wong C.K. Yau C. Hayes D.N. Parker J.S. Wilkerson M.D. Ally A. Balasundaram M. Bowlby R. Brooks D. Carlsen R. Chuah E. Dhalla N. Holt R. Jones S.J.M. Kasaian K. Lee D. Ma Y. Marra M.A. Mayo M. Moore R.A. Mungall A.J. Mungall K. Robertson A.G. Sadeghi S. Schein J.E. Sipahimalani P. Tam A. Thiessen N. Tse K. Wong T. Berger A.C. Beroukhim R. Cherniack A.D. Cibulskis C. Gabriel S.B. Gao G.F. Ha G. Meyerson M. Schumacher S.E. Shih J. Kucherlapati M.H. Kucherlapati R.S. Baylin S. Cope L. Danilova L. Bootwalla M.S. Lai P.H. Maglinte D.T. Van Den Berg D.J. Weisenberger D.J. Auman J.T. Balu S. Bodenheimer T. Fan C. Hoadley K.A. Hoyle A.P. Jefferys S.R. Jones C.D. Meng S. Mieczkowski P.A. Mose L.E. Perou A.H. Perou C.M. Roach J. Shi Y. Simons J.V. Skelly T. Soloway M.G. Tan D. Veluvolu U. Fan H. Hinoue T. Laird P.W. Shen H. Zhou W. Bellair M. Chang K. Covington K. Creighton C.J. Dinh H. Doddapaneni H.V. Donehower L.A. Drummond J. Gibbs R.A. Glenn R. Hale W. Han Y. Hu J. Korchina V. Lee S. Lewis L. Li W. Liu X. Morgan M. Morton D. Muzny D. Santibanez J. Sheth M. Shinbro E. Wang L. Wang M. Wheeler D.A. Xi L. Zhao F. Hess J. Appelbaum E.L. Bailey M. Cordes M.G. Ding L. Fronick C.C. Fulton L.A. Fulton R.S. Kandoth C. Mardis E.R. McLellan M.D. Miller C.A. Schmidt H.K. Wilson R.K. Crain D. Curley E. Gardner J. Lau K. Mallery D. Morris S. Paulauskis J. Penny R. Shelton C. Shelton T. Sherman M. Thompson E. Yena P. Bowen J. Gastier-Foster J.M. Gerken M. Leraas K.M. Lichtenberg T.M. Ramirez N.C. Wise L. Zmuda E. Corcoran N. Costello T. Hovens C. Carvalho A.L. de Carvalho A.C. Fregnani J.H. Longatto-Filho A. Reis R.M. Scapulatempo-Neto C. Silveira H.C.S. Vidal D.O. Burnette A. Eschbacher J. Hermes B. Noss A. Singh R. Anderson M.L. Castro P.D. Ittmann M. Huntsman D. Kohl B. Le X. Thorp R. Andry C. Duffy E.R. Lyadov V. Paklina O. Setdikova G. Shabunin A. Tavobilov M. McPherson C. Warnick R. Berkowitz R. Cramer D. Feltmate C. Horowitz N. Kibel A. Muto M. Raut C.P. Malykh A. Barnholtz-Sloan J.S. Barrett W. Devine K. Fulop J. Ostrom Q.T. Shimmel K. Wolinsky Y. Sloan A.E. De Rose A. Giuliante F. Goodman M. Karlan B.Y. Hagedorn C.H. Eckman J. Harr J. Myers J. Tucker K. Zach L.A. Deyarmin B. Hu H. Kvecher L. Larson C. Mural R.J. Somiari S. Vicha A. Zelinka T. Bennett J. Iacocca M. Rabeno B. Swanson P. Latour M. Lacombe L. Têtu B. Bergeron A. McGraw M. Staugaitis S.M. Chabot J. Hibshoosh H. Sepulveda A. Su T. Wang T. Potapova O. Voronina O. Desjardins L. Mariani O. Roman-Roman S. Sastre X. Stern M-H. Cheng F. Signoretti S. Berchuck A. Bigner D. Lipp E. Marks J. McCall S. McLendon R. Secord A. Sharp A. Behera M. Brat D.J. Chen A. Delman K. Force S. Khuri F. Magliocca K. Maithel S. Olson J.J. Owonikoko T. Pickens A. Ramalingam S. Shin D.M. Sica G. Van Meir E.G. Zhang H. Eijckenboom W. Gillis A. Korpershoek E. Looijenga L. Oosterhuis W. Stoop H. van Kessel K.E. Zwarthoff E.C. Calatozzolo C. Cuppini L. Cuzzubbo S. DiMeco F. Finocchiaro G. Mattei L. Perin A. Pollo B. Chen C. Houck J. Lohavanichbutr P. Hartmann A. Stoehr C. Stoehr R. Taubert H. Wach S. Wullich B. Kycler W. Murawa D. Wiznerowicz M. Chung K. Edenfield W.J. Martin J. Baudin E. Bubley G. Bueno R. De Rienzo A. Richards W.G. Kalkanis S. Mikkelsen T. Noushmehr H. Scarpace L. Girard N. Aymerich M. Campo E. Giné E. Guillermo A.L. Van Bang N. Hanh P.T. Phu B.D. Tang Y. Colman H. Evason K. Dottino P.R. Martignetti J.A. Gabra H. Juhl H. Akeredolu T. Stepa S. Hoon D. Ahn K. Kang K.J. Beuschlein F. Breggia A. Birrer M. Bell D. Borad M. Bryce A.H. Castle E. Chandan V. Cheville J. Copland J.A. Farnell M. Flotte T. Giama N. Ho T. Kendrick M. Kocher J-P. Kopp K. Moser C. Nagorney D. O’Brien D. O’Neill B.P. Patel T. Petersen G. Que F. Rivera M. Roberts L. Smallridge R. Smyrk T. Stanton M. Thompson R.H. Torbenson M. Yang J.D. Zhang L. Brimo F. Ajani J.A. Angulo Gonzalez A.M. Behrens C. Bondaruk J. Broaddus R. Czerniak B. Esmaeli B. Fujimoto J. Gershenwald J. Guo C. Lazar A.J. Logothetis C. Meric-Bernstam F. Moran C. Ramondetta L. Rice D. Sood A. Tamboli P. Thompson T. Troncoso P. Tsao A. Wistuba I. Carter C. Haydu L. Hersey P. Jakrot V. Kakavand H. Kefford R. Lee K. Long G. Mann G. Quinn M. Saw R. Scolyer R. Shannon K. Spillane A. Stretch J. Synott M. Thompson J. Wilmott J. Al-Ahmadie H. Chan T.A. Ghossein R. Gopalan A. Levine D.A. Reuter V. Singer S. Singh B. Tien N.V. Broudy T. Mirsaidi C. Nair P. Drwiega P. Miller J. Smith J. Zaren H. Park J-W. Hung N.P. Kebebew E. Linehan W.M. Metwalli A.R. Pacak K. Pinto P.A. Schiffman M. Schmidt L.S. Vocke C.D. Wentzensen N. Worrell R. Yang H. Moncrieff M. Goparaju C. Melamed J. Pass H. Botnariuc N. Caraman I. Cernat M. Chemencedji I. Clipca A. Doruc S. Gorincioi G. Mura S. Pirtac M. Stancul I. Tcaciuc D. Albert M. Alexopoulou I. Arnaout A. Bartlett J. Engel J. Gilbert S. Parfitt J. Sekhon H. Thomas G. Rassl D.M. Rintoul R.C. Bifulco C. Tamakawa R. Urba W. Hayward N. Timmers H. Antenucci A. Facciolo F. Grazi G. Marino M. Merola R. de Krijger R. Gimenez-Roqueplo A-P. Piché A. Chevalier S. McKercher G. Birsoy K. Barnett G. Brewer C. Farver C. Naska T. Pennell N.A. Raymond D. Schilero C. Smolenski K. Williams F. Morrison C. Borgia J.A. Liptay M.J. Pool M. Seder C.W. Junker K. Omberg L. Dinkin M. Manikhas G. Alvaro D. Bragazzi M.C. Cardinale V. Carpino G. Gaudio E. Chesla D. Cottingham S. Dubina M. Moiseenko F. Dhanasekaran R. Becker K-F. Janssen K-P. Slotta-Huspenina J. Abdel-Rahman M.H. Aziz D. Bell S. Cebulla C.M. Davis A. Duell R. Elder J.B. Hilty J. Kumar B. Lang J. Lehman N.L. Mandt R. Nguyen P. Pilarski R. Rai K. Schoenfield L. Senecal K. Wakely P. Hansen P. Lechan R. Powers J. Tischler A. Grizzle W.E. Sexton K.C. Kastl A. Henderson J. Porten S. Waldmann J. Fassnacht M. Asa S.L. Schadendorf D. Couce M. Graefen M. Huland H. Sauter G. Schlomm T. Simon R. Tennstedt P. Olabode O. Nelson M. Bathe O. Carroll P.R. Chan J.M. Disaia P. Glenn P. Kelley R.K. Landen C.N. Phillips J. Prados M. Simko J. Smith-McCune K. VandenBerg S. Roggin K. Fehrenbach A. Kendler A. Sifri S. Steele R. Jimeno A. Carey F. Forgie I. Mannelli M. Carney M. Hernandez B. Campos B. Herold-Mende C. Jungk C. Unterberg A. von Deimling A. Bossler A. Galbraith J. Jacobus L. Knudson M. Knutson T. Ma D. Milhem M. Sigmund R. Godwin A.K. Madan R. Rosenthal H.G. Adebamowo C. Adebamowo S.N. Boussioutas A. Beer D. Giordano T. Mes-Masson A-M. Saad F. Bocklage T. Landrum L. Mannel R. Moore K. Moxley K. Postier R. Walker J. Zuna R. Feldman M. Valdivieso F. Dhir R. Luketich J. Mora Pinero E.M. Quintero-Aguilo M. Carlotti C.G. Dos Santos J.S. Kemp R. Sankarankuty A. Tirapelli D. Catto J. Agnew K. Swisher E. Creaney J. Robinson B. Shelley C.S. Godwin E.M. Kendall S. Shipman C. Bradford C. Carey T. Haddad A. Moyer J. Peterson L. Prince M. Rozek L. Wolf G. Bowman R. Fong K.M. Yang I. Korst R. Rathmell W.K. Fantacone-Campbell J.L. Hooke J.A. Kovatich A.J. Shriver C.D. DiPersio J. Drake B. Govindan R. Heath S. Ley T. Van Tine B. Westervelt P. Rubin M.A. Lee J.I. Aredes N.D. Mariamidze A. Hu H. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 2018 173 2 400 416.e11 10.1016/j.cell.2018.02.052 29625055
    [Google Scholar]
  33. Yu G. Wang L.G. Han Y. He Q.Y. clusterProfiler: An R package for comparing biological themes among gene clusters. OMICS 2012 16 5 284 287 10.1089/omi.2011.0118 22455463
    [Google Scholar]
  34. Li T. Fu J. Zeng Z. Cohen D. Li J. Chen Q. Li B. Liu X.S. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020 48 W1 W509 W514 10.1093/nar/gkaa407 32442275
    [Google Scholar]
  35. Yoshihara K. Shahmoradgoli M. Martínez E. Vegesna R. Kim H. Torres-Garcia W. Treviño V. Shen H. Laird P.W. Levine D.A. Carter S.L. Getz G. Stemke-Hale K. Mills G.B. Verhaak R.G.W. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 2013 4 1 2612 10.1038/ncomms3612 24113773
    [Google Scholar]
  36. Zeng J. Zhang Y. Shang Y. Mai J. Shi S. Lu M. Bu C. Zhang Z. Zhang Z. Li Y. Du Z. Xiao J. CancerSCEM: A database of single-cell expression map across various human cancers. Nucleic Acids Res. 2022 50 D1 D1147 D1155 10.1093/nar/gkab905 34643725
    [Google Scholar]
  37. Zhang B. Hu Q. Li Y. Xu C. Xie X. Liu P. Xu M. Gong S. Wu H. Diaphanous-related formin subfamily: Novel prognostic biomarkers and tumor microenvironment regulators for pancreatic adenocarcinoma. Front. Mol. Biosci. 2022 9 910950 10.3389/fmolb.2022.910950 36589226
    [Google Scholar]
  38. Rizzardi A.E. Johnson A.T. Vogel R.I. Pambuccian S.E. Henriksen J. Skubitz A.P.N. Metzger G.J. Schmechel S.C. Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn. Pathol. 2012 7 1 42 10.1186/1746‑1596‑7‑42 22515559
    [Google Scholar]
  39. Drechsler H. McHugh T. Singleton M.R. Carter N.J. McAinsh A.D. The Kinesin-12 Kif15 is a processive track-switching tetramer. eLife 2014 3 e01724 10.7554/eLife.01724 24668168
    [Google Scholar]
  40. Salazar B.M. Ohi R. Antiparallel microtubule bundling supports KIF15-driven mitotic spindle assembly. Mol. Biol. Cell 2024 35 6 ar84 10.1091/mbc.E24‑01‑0023 38598297
    [Google Scholar]
  41. Wang Z. Chen M. Fang X. Hong H. Yao Y. Huang H. KIF15 is involved in development and progression of Burkitt lymphoma. Cancer Cell Int. 2021 21 1 261 10.1186/s12935‑021‑01967‑z 33985517
    [Google Scholar]
  42. Zeng H. Li T. Zhai D. Bi J. Kuang X. Lu S. Shan Z. Lin Y. ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. Int. J. Biol. Sci. 2020 16 12 2084 2093 10.7150/ijbs.44204 32549756
    [Google Scholar]
  43. Quan G. Xu J. Wang J. Liu X. Xu J. Jiang J. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. Cell Death Dis. 2023 14 2 137 10.1038/s41419‑023‑05679‑2 36807568
    [Google Scholar]
  44. Qiao Y. Chen J. Ma C. Liu Y. Li P. Wang Y. Hou L. Liu Z. Increased KIF15 expression predicts a poor prognosis in patients with lung adenocarcinoma. Cell. Physiol. Biochem. 2018 51 1 1 10 10.1159/000495155 30439711
    [Google Scholar]
  45. Kitagawa A. Masuda T. Takahashi J. Tobo T. Noda M. Kuroda Y. Hu Q. Kouyama Y. Kobayashi Y. Kuramitsu S. Sato K. Fujii A. Yoshikawa Y. Wakiyama H. Shimizu D. Tsuruda Y. Eguchi H. Doki Y. Mori M. Mimori K. KIF15 expression in tumor-associated monocytes is a prognostic biomarker in hepatocellular carcinoma. Cancer Genomics Proteomics 2020 17 2 141 149 10.21873/cgp.20174 32108036
    [Google Scholar]
  46. Ding L. Li B. Yu X. Li Z. Li X. Dang S. Lv Q. Wei J. Sun H. Chen H. Liu M. Li G. KIF15 facilitates gastric cancer via enhancing proliferation, inhibiting apoptosis, and predict poor prognosis. Cancer Cell Int. 2020 20 1 125 10.1186/s12935‑020‑01199‑7 32322172
    [Google Scholar]
  47. Tao J. Sun G. Li Q. Zhi X. Li Z. He Z. Chen H. Zhou A. Ye J. Xu G. Guan W. Zhang W. KIF15 promotes the evolution of gastric cancer cells through inhibition of reactive oxygen species‐mediated apoptosis. J. Cell. Physiol. 2020 235 12 9388 9398 10.1002/jcp.29743 32342525
    [Google Scholar]
  48. Jiang K. Rezabkova L. Hua S. Liu Q. Capitani G. Altelaar A.F.M. Heck A.J.R. Kammerer R.A. Steinmetz M.O. Akhmanova A. Microtubule minus-end regulation at spindle poles by an ASPM–katanin complex. Nat. Cell Biol. 2017 19 5 480 492 10.1038/ncb3511 28436967
    [Google Scholar]
  49. Bond J. Roberts E. Mochida G.H. Hampshire D.J. Scott S. Askham J.M. Springell K. Mahadevan M. Crow Y.J. Markham A.F. Walsh C.A. Woods C.G. ASPM is a major determinant of cerebral cortical size. Nat. Genet. 2002 32 2 316 320 10.1038/ng995 12355089
    [Google Scholar]
  50. Pai V.C. Hsu C.C. Chan T.S. Liao W.Y. Chuu C.P. Chen W.Y. Li C.R. Lin C.Y. Huang S.P. Chen L.T. Tsai K.K. ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling. Oncogene 2019 38 8 1340 1353 10.1038/s41388‑018‑0497‑4 30266990
    [Google Scholar]
  51. Hsu C.C. Liao W.Y. Chang K.Y. Chan T.S. Huang P.J. Chiang C.T. Shan Y.S. Cheng L.H. Liao T.Y. Tsai K.K. A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer. Gastric Cancer 2021 24 3 624 639 10.1007/s10120‑020‑01154‑5 33515163
    [Google Scholar]
  52. Lin S.Y. Pan H.W. Liu S.H. Jeng Y.M. Hu F.C. Peng S.Y. Lai P.L. Hsu H.C. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Clin. Cancer Res. 2008 14 15 4814 4820 10.1158/1078‑0432.CCR‑07‑5262 18676753
    [Google Scholar]
  53. Zhang Y. Che N. Wang S. Meng J. Zhao N. Han J. Dong X. Li Y. Mo J. Zhao X. Liu T. Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia. J. Gastroenterol. 2024 59 10 941 957 10.1007/s00535‑024‑02140‑9 39097533
    [Google Scholar]
  54. Viale G. Giobbie-Hurder A. Regan M.M. Coates A.S. Mastropasqua M.G. Dell’Orto P. Maiorano E. MacGrogan G. Braye S.G. Öhlschlegel C. Neven P. Orosz Z. Olszewski W.P. Knox F. Thürlimann B. Price K.N. Castiglione-Gertsch M. Gelber R.D. Gusterson B.A. Goldhirsch A. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: Results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J. Clin. Oncol. 2008 26 34 5569 5575 10.1200/JCO.2008.17.0829 18981464
    [Google Scholar]
  55. Khor L.Y. Bae K. Paulus R. Al-Saleem T. Hammond M.E. Grignon D.J. Che M. Venkatesan V. Byhardt R.W. Rotman M. Hanks G.E. Sandler H.M. Pollack A. MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02. J. Clin. Oncol. 2009 27 19 3177 3184 10.1200/JCO.2008.19.8267 19470936
    [Google Scholar]
  56. Mrouj K. Andrés-Sánchez N. Dubra G. Singh P. Sobecki M. Chahar D. Al Ghoul E. Aznar A.B. Prieto S. Pirot N. Bernex F. Bordignon B. Hassen-Khodja C. Villalba M. Krasinska L. Fisher D. Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proc. Natl. Acad. Sci. USA 2021 118 10 e2026507118 10.1073/pnas.2026507118 33658388
    [Google Scholar]
  57. Li J. Dallmayer M. Kirchner T. Musa J. Grünewald T.G.P. PRC1: Linking cytokinesis, chromosomal instability, and cancer evolution. Trends Cancer 2018 4 1 59 73 10.1016/j.trecan.2017.11.002 29413422
    [Google Scholar]
  58. Zhan P. Zhang B. Xi G. Wu Y. Liu H. Liu Y. Xu W. Zhu Q. Cai F. Zhou Z. Miu Y. Wang X. Jin J. Li Q. Qian L. Lv T. Song Y. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway. Mol. Cancer 2017 16 1 108 10.1186/s12943‑017‑0682‑z 28646916
    [Google Scholar]
  59. Bakhoum M.F. Francis J.H. Agustinus A. Earlie E.M. Di Bona M. Abramson D.H. Duran M. Masilionis I. Molina E. Shoushtari A.N. Goldbaum M.H. Mischel P.S. Bakhoum S.F. Laughney A.M. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression. Nat. Commun. 2021 12 1 5402 10.1038/s41467‑021‑25529‑z 34518527
    [Google Scholar]
  60. Piunti A. Shilatifard A. The roles of Polycomb repressive complexes in mammalian development and cancer. Nat. Rev. Mol. Cell Biol. 2021 22 5 326 345 10.1038/s41580‑021‑00341‑1 33723438
    [Google Scholar]
  61. Gao L. Zhang W. Zhang J. Liu J. Sun F. Liu H. Hu J. Wang X. Wang X. Su P. Chen S. Qu S. Shi B. Xiong X. Chen W. Dong X. Han B. KIF15-mediated stabilization of AR and AR-V7 contributes to enzalutamide resistance in prostate cancer. Cancer Res. 2021 81 4 1026 1039 10.1158/0008‑5472.CAN‑20‑1965 33277366
    [Google Scholar]
  62. Ma Y. Zhan S. Lu H. Wang R. Xu Y. Zhang G. Cao L. Shi T. Zhang X. Chen W. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer. Cell Death Dis. 2020 11 10 824 10.1038/s41419‑020‑03041‑4 33011740
    [Google Scholar]
  63. Jin M.Z. Jin W.L. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct. Target. Ther. 2020 5 1 166 10.1038/s41392‑020‑00280‑x 32843638
    [Google Scholar]
  64. Aliazis K. Christofides A. Shah R. Yeo Y.Y. Jiang S. Charest A. Boussiotis V.A. The tumor microenvironment’s role in the response to immune checkpoint blockade. Nat. Cancer 2025 6 6 924 937 10.1038/s43018‑025‑00986‑3 40514448
    [Google Scholar]
  65. Elhanani O. Ben-Uri R. Keren L. Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell 2023 41 3 404 420 10.1016/j.ccell.2023.01.010 36800999
    [Google Scholar]
  66. Pagès F. André T. Taieb J. Vernerey D. Henriques J. Borg C. Marliot F. Ben Jannet R. Louvet C. Mineur L. Bennouna J. Desrame J. Faroux R. Kirilovsky A. Duval A. Laurent-Puig P. Svrcek M. Hermitte F. Catteau A. Galon J. Emile J.F. Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. Ann. Oncol. 2020 31 7 921 929 10.1016/j.annonc.2020.03.310 32294529
    [Google Scholar]
  67. Bruni D. Angell H.K. Galon J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer 2020 20 11 662 680 10.1038/s41568‑020‑0285‑7 32753728
    [Google Scholar]
  68. Galon J. Bruni D. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat. Rev. Drug Discov. 2019 18 3 197 218 10.1038/s41573‑018‑0007‑y 30610226
    [Google Scholar]
  69. Pagès F. Mlecnik B. Marliot F. Bindea G. Ou F.S. Bifulco C. Lugli A. Zlobec I. Rau T.T. Berger M.D. Nagtegaal I.D. Vink-Börger E. Hartmann A. Geppert C. Kolwelter J. Merkel S. Grützmann R. Van den Eynde M. Jouret-Mourin A. Kartheuser A. Léonard D. Remue C. Wang J.Y. Bavi P. Roehrl M.H.A. Ohashi P.S. Nguyen L.T. Han S. MacGregor H.L. Hafezi-Bakhtiari S. Wouters B.G. Masucci G.V. Andersson E.K. Zavadova E. Vocka M. Spacek J. Petruzelka L. Konopasek B. Dundr P. Skalova H. Nemejcova K. Botti G. Tatangelo F. Delrio P. Ciliberto G. Maio M. Laghi L. Grizzi F. Fredriksen T. Buttard B. Angelova M. Vasaturo A. Maby P. Church S.E. Angell H.K. Lafontaine L. Bruni D. El Sissy C. Haicheur N. Kirilovsky A. Berger A. Lagorce C. Meyers J.P. Paustian C. Feng Z. Ballesteros-Merino C. Dijkstra J. van de Water C. van Lent-van Vliet S. Knijn N. Mușină A.M. Scripcariu D.V. Popivanova B. Xu M. Fujita T. Hazama S. Suzuki N. Nagano H. Okuno K. Torigoe T. Sato N. Furuhata T. Takemasa I. Itoh K. Patel P.S. Vora H.H. Shah B. Patel J.B. Rajvik K.N. Pandya S.J. Shukla S.N. Wang Y. Zhang G. Kawakami Y. Marincola F.M. Ascierto P.A. Sargent D.J. Fox B.A. Galon J. International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet 2018 391 10135 2128 2139 10.1016/S0140‑6736(18)30789‑X 29754777
    [Google Scholar]
  70. Gabrilovich D.I. Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009 9 3 162 174 10.1038/nri2506 19197294
    [Google Scholar]
  71. Erin N. Grahovac J. Brozovic A. Efferth T. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resist. Updat. 2020 53 100715 10.1016/j.drup.2020.100715 32679188
    [Google Scholar]
  72. Wu Y. Yi M. Niu M. Mei Q. Wu K. Myeloid-derived suppressor cells: An emerging target for anticancer immunotherapy. Mol. Cancer 2022 21 1 184 10.1186/s12943‑022‑01657‑y 36163047
    [Google Scholar]
  73. Lasser S.A. Ozbay Kurt F.G. Arkhypov I. Utikal J. Umansky V. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat. Rev. Clin. Oncol. 2024 21 2 147 164 10.1038/s41571‑023‑00846‑y 38191922
    [Google Scholar]
  74. Zhang S. Tu Q. Qian X. Wang J. Ma C. Yang L. Liu Y. Wu R. Liu M. Deficiency of Kif15 gene inhibits tumor growth due to host CD8+T lymphocytes increase. Biochem. Biophys. Res. Commun. 2023 655 110 117 10.1016/j.bbrc.2023.03.006 36934586
    [Google Scholar]
  75. Jiao Z-Y. Sun R-F. He N. Zhang G-Y. Yu Z-Y. Li L-S. Ma Z-J. Combined Inhibition of KIF11 and KIF15 as an Effective Therapeutic Strategy for Gastric Cancer. Curr. Cancer Drug Targets 2023 23 4 293 306 10.2174/1568009622666220616122846 35713129
    [Google Scholar]
/content/journals/ccdt/10.2174/0115680096420482251130063549
Loading
In Silico Multi-omics Analyses of Kinesin Family Member 15 in Pan-Cancer and Validation in Tissue Microarray
Bentham Science Publishers ; https://doi.org/10.2174/0115680096420482251130063549
/content/journals/ccdt/10.2174/0115680096420482251130063549
/content/journals/ccdt/10.2174/0115680096420482251130063549
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: KIF15 ; immune infiltration ; bioinformatics ; pan-cancer ; myeloid-derived suppressor cells ; tissue microarray

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test